Migraine News and Research

Latest Migraine News and Research

Leisure activities may help lower the risk of dementia

Leisure activities, such as reading a book, doing yoga and spending time with family and friends, may help lower the risk of dementia, according to a new meta-analysis published in the August 10, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

10 Aug 2022

Elevated stress during the pandemic impacted the quality of life for kids with headache disorders

Since the beginning of the COVID-19 pandemic, many pediatric patients who suffer from headaches have experienced more frequent headaches and worsening anxiety and mood, and a new study finds links to stress, decreased physical activity and increased screen time.

5 Aug 2022

Physical and mental activities may help reduce dementia risk

Physical and mental activities, such as household chores, exercise, and visiting with family and friends, may help lower the risk of dementia, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

People who eat more ultra-processed foods may have higher risk of dementia

People who eat the highest amounts of ultra-processed foods like soft drinks, chips and cookies may have a higher risk of developing dementia than those who eat the lowest amounts, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

PCORI approves $258 million funding to support 26 new health care-related studies

The Patient-Centered Outcomes Research Institute has approved funding awards totaling $258 million to support 26 new research studies.

26 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Benefits of physical, mental activity on thinking may vary for men and women, study suggests

Studies have shown that physical and mental activity help preserve thinking skills and delay dementia. A new study suggests that these benefits may vary for men and women.

20 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 19 Jul 2022

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

UCSF Perspective Article Says New Ruling May Result in Increased Risk of Deaths, Disability.

14 Jul 2022

Few people may have symptoms of depression years before their stroke, finds study

While depression is a common problem for people who have had a stroke, some people may have symptoms of depression years before their stroke, according to a study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Jul 2022

People with non-alcoholic fatty liver disease may have higher risk of dementia

People who have non-alcoholic fatty liver disease, a buildup of fat cells in the liver, may have a higher risk of dementia, according to a new study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Jul 2022

Commonly prescribed class of migraine drugs may be effective in treating obesity

Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a new study by scientists at UT Southwestern suggests.

11 Jul 2022

Study finds more of white matter hyperintensities in postmenopausal women

Women who have gone through menopause may have more of a brain biomarker called white matter hyperintensities than premenopausal women or men of the same age, according to a new study published in the June 29, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Jun 2022

Innovative treatment reduces post-traumatic headache related disability, study finds

The first therapy to be developed specifically for post-traumatic headache significantly reduced related disability in veterans following a traumatic brain injury (TBI).

27 Jun 2022

Study provides better understanding of the brain pathways that control nausea

Nausea is a bit of a catchall sensation for the human body: the unpleasant sick feeling can hit us as a result of everything from pregnancy or a migraine to eating spoiled food or undergoing chemotherapy.

22 Jun 2022

Acupuncture may help people suffering from chronic tension-type headaches

Acupuncture may reduce headaches for people who have chronic tension-type headaches, according to a study published in the June 22, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

22 Jun 2022

Neuropsychiatric symptoms among patients with long COVID

More than two years after the COVID-19 pandemic erupted, scientists have become increasingly aware of a group of patients - so-called 'long haulers' - who remain plagued by a combination of symptoms long after the infection passes.

17 Jun 2022

Cost of brand-name antiseizure medications increased by 277% from 2010 to 2018, study finds

The cost of brand-name drugs for epilepsy increased by 277% from 2010 to 2018, according to a study published in the June 15, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Jun 2022

Taking valproic acid during pregnancy can cause birth defects, study shows

Valproic acid - a drug used to treat epilepsy, migraine, and bipolar disorder - can cause birth defects when taken during pregnancy.

14 Jun 2022

Shingles is not associated with increased risk of dementia, finds study

Shingles, a viral infection caused by the reactivation of the chickenpox virus, results in a painful blistering rash along one side of the body or face from nerve inflammation. There has been scientific speculation that such inflammation may increase a person's risk of dementia.

9 Jun 2022

Migraine News and Research

Latest Migraine News and Research

Leisure activities may help lower the risk of dementia

Elevated stress during the pandemic impacted the quality of life for kids with headache disorders

Physical and mental activities may help reduce dementia risk

People who eat more ultra-processed foods may have higher risk of dementia

PCORI approves $258 million funding to support 26 new health care-related studies

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Benefits of physical, mental activity on thinking may vary for men and women, study suggests

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

Few people may have symptoms of depression years before their stroke, finds study

People with non-alcoholic fatty liver disease may have higher risk of dementia

Commonly prescribed class of migraine drugs may be effective in treating obesity

Study finds more of white matter hyperintensities in postmenopausal women

Innovative treatment reduces post-traumatic headache related disability, study finds

Study provides better understanding of the brain pathways that control nausea

Acupuncture may help people suffering from chronic tension-type headaches

Neuropsychiatric symptoms among patients with long COVID

Cost of brand-name antiseizure medications increased by 277% from 2010 to 2018, study finds

Taking valproic acid during pregnancy can cause birth defects, study shows

Shingles is not associated with increased risk of dementia, finds study

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Migraine News and Research

Latest Migraine News and Research

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in